Profile
Daniel D. Shoemaker holds the position of Chief Scientific Officer for Fate Therapeutics, Inc. He previously was Chief Scientific Officer at ICX Biosystem, Chief Scientific Officer at GHC Technologies, Inc. and Director-Target Discovery at Merck Research Laboratories Massachusetts LLC. Dr. Shoemaker received a doctorate from Stanford University and an undergraduate degree from the University of California, Santa Barbara.
Former positions of Daniel Shoemaker
| Companies | Position | End |
|---|---|---|
| FATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-06-29 |
ICX Biosystem | Chief Tech/Sci/R&D Officer | 2008-12-31 |
GHC Technologies, Inc.
GHC Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies for molecular diagnosis | Chief Tech/Sci/R&D Officer | 2002-12-31 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | 2002-12-31 |
Rosetta Inpharmatics LLC
Rosetta Inpharmatics LLC BiotechnologyHealth Technology Develops and implements drug discovery technology | Director/Board Member | - |
Training of Daniel Shoemaker
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Rosetta Inpharmatics LLC
Rosetta Inpharmatics LLC BiotechnologyHealth Technology Develops and implements drug discovery technology | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GHC Technologies, Inc.
GHC Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies for molecular diagnosis | Commercial Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Fate Therapeutics, Inc.
Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
ICX Biosystem |
- Stock Market
- Insiders
- Daniel Shoemaker
















